Filtrer vos résultats
- 3
- 1
- 3
- 1
- 4
- 4
- 4
- 3
- 3
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
P105 Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicityQJM: An International Journal of Medicine, 2016, 109 (suppl_1), pp.S58. ⟨10.1093/qjmed/hcw120.006⟩
Article dans une revue
hal-01512940v1
|
||
|
P087 Inhibition of pleural inflammation hampers with bleomycin-induced lung profibrotic toxicity.QJM: An International Journal of Medicine, 2016, 109 (suppl_1), pp.S51. ⟨10.1093/qjmed/hcw127.023⟩
Article dans une revue
hal-01512935v1
|
||
|
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycinRespiratory Research, 2016, 17 (1), ⟨10.1186/s12931-016-0475-8⟩
Article dans une revue
hal-01438793v1
|
||
LSC Abstract – Pleural inflammation is essential in bleomycin-induced lung toxicityERS International Congress 2016, Londres, Sep 2016, Londres, United Kingdom. pp.PP212, ⟨10.1183/13993003.congress-2016.PP212⟩
Communication dans un congrès
hal-01578972v1
|